Sadleir, Lynette G.
Seattle Children's Hospital · University of Washington · Brotman Baty Institute · University of Otago
17 papers on CoChatORCID 0000-0002-5355-7115
Most cited papers
- Verified
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1
Carvill, G. L., Heavin, S. B., Yendle, S. C., McMahon, J. M., O'Roak, B. J., Cook, J., Khan, A., Dorschner, M. O., Weaver, M., Calvert, S., et al. (2013) · Nature Genetics
Epilepsy research and treatmentGenomics and Rare Diseases
Cited by 687
- Verified
High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies
Hamdan, F. F., Myers, C. T., Cossette, P., Lemay, P., Spiegelman, D., Laporte, A. D., Nassif, C., Diallo, O., Monlong, J., Cadieux-Dion, M., et al. (2017) · The American Journal of Human Genetics
Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders
Cited by 445
- Verified
De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies
Appenzeller, S., Balling, R., Barisic, N., Baulac, S., Caglayan, H., Craiu, D., De Jonghe, P., Depienne, C., Dimova, P., Djémié, T., et al. (2014) · The American Journal of Human Genetics
Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders
Cited by 439
- Verified
De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies
Myers, C. T., McMahon, J. M., Schneider, A. L., Petrovski, S., Allen, A. S., Carvill, G. L., Zemel, M., Saykally, J. E., LaCroix, A. J., Heinzen, E. L., et al. (2016) · The American Journal of Human Genetics
Epilepsy research and treatmentGenomics and Rare Diseases
Cited by 287
- Verified
Rare copy number variants are an important cause of epileptic encephalopathies
Mefford, H. C., Yendle, S. C., Hsu, C., Cook, J., Geraghty, E., McMahon, J. M., Eeg‐Olofsson, O., Sadleir, L. G., Gill, D., Ben‐Zeev, B., et al. (2011) · Annals of Neurology
Genomic variations and chromosomal abnormalitiesEpilepsy research and treatment
Cited by 247
- Verified
Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial
O'Callaghan, F. J. K., Edwards, S. W., Alber, F. D., Cortina Borja, M., Hancock, E., Johnson, A. L., Kennedy, C. R., Likeman, M., Lux, A. L., Mackay, M. T., et al. (2018) · The Lancet Child & Adolescent Health
Epilepsy research and treatmentPharmacological Effects and Toxicity Studies
Cited by 167
- Verified
Heart rate variability in epilepsy: A potential biomarker of sudden unexpected death in epilepsy risk
Myers, K. A., Bello‐Espinosa, L. E., Symonds, J. D., Zuberi, S. M., Clegg, R., Sadleir, L. G., Buchhalter, J., & Scheffer, I. E. (2018) · Epilepsia
Epilepsy research and treatmentHeart Rate Variability and Autonomic Control
Cited by 151
- Verified
The Genetic Landscape of Epilepsy of Infancy with Migrating Focal Seizures
Burgess, R., Wang, S., McTague, A., Boysen, K. E., Yang, X., Zeng, Q., Myers, K. A., Rochtus, A., Trivisano, M., Gill, D., et al. (2019) · Annals of Neurology
Epilepsy research and treatmentIon channel regulation and function
Cited by 141
- Verified
Parental Mosaicism in “De Novo” Epileptic Encephalopathies
Myers, C. T., Hollingsworth, G., Muir, A. M., Schneider, A. L., Thuesmunn, Z., Knupp, A., King, C., Lacroix, A., Mehaffey, M. G., Berkovic, S. F., et al. (2018) · New England Journal of Medicine
Epilepsy research and treatmentGenomic variations and chromosomal abnormalities
Cited by 139
- Verified
Not all SCN1A epileptic encephalopathies are Dravet syndrome: Early profound Thr226Met phenotype
Sadleir, L. G., Mountier, E. I., Gill, D., Davis, S., Joshi, C., DeVile, C., Kurian, M. A., Study, F. T. D., Mandelstam, S., Wirrell, E., et al. (2017) · Neurology
Epilepsy research and treatmentIon channel regulation and function
Cited by 131
- Verified
Epidemiology of Developmental and Epileptic Encephalopathy and of Intellectual Disability and Epilepsy in Children
Poke, G., Stanley, J., Scheffer, I. E., & Sadleir, L. G. (2023) · Neurology
Epilepsy research and treatmentPharmacological Effects and Toxicity Studies
Cited by 96
- Verified
New insights into the clinical and molecular spectrum of the novel CYFIP2-related neurodevelopmental disorder and impairment of the WRC-mediated actin dynamics
Begemann, A., Sticht, H., Begtrup, A., Vitobello, A., Faivre, L., Banka, S., Alhaddad, B., Asadollahi, R., Becker, J., Bierhals, T., et al. (2021) · Genetics in Medicine
Genetics and Neurodevelopmental DisordersGenomics and Rare Diseases
Cited by 61
- Verified
NEXMIF encephalopathy: an X-linked disorder with male and female phenotypic patterns
Stamberger, H., Hammer, T. B., Gardella, E., Vlaskamp, D. R. M., Bertelsen, B., Mandelstam, S., de Lange, I., Zhang, J., Myers, C. T., Fenger, C., et al. (2021) · Genetics in Medicine
Genetics and Neurodevelopmental DisordersEpilepsy research and treatment
Cited by 57
- Verified
Schizophrenia is a later‐onset feature ofPCDH 19 Girls Clustering Epilepsy
Vlaskamp, D. R. M., Bassett, A. S., Sullivan, J. E., Robblee, J., Sadleir, L. G., Scheffer, I. E., & Andrade, D. M. (2019) · Epilepsia
Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders
Cited by 39
- Verified
Diagnostic utility of DNA methylation analysis in genetically unsolved pediatric epilepsies and CHD2 episignature refinement
LaFlamme, C. W., Rastin, C., Sengupta, S., Pennington, H. E., Russ-Hall, S. J., Schneider, A. L., Bonkowski, E. S., Almanza Fuerte, E. P., Allan, T. J., Zalusky, M. P.-G., et al. (2024) · Nature Communications
Epilepsy research and treatmentEpigenetics and DNA Methylation
Cited by 31
- Verified
Solving the Etiology of Developmental and Epileptic Encephalopathy with Spike–Wave Activation in Sleep (D/EE‐SWAS )
Viswanathan, S., Oliver, K. L., Regan, B. M., Schneider, A. L., Myers, C. T., Mehaffey, M. G., LaCroix, A. J., Antony, J., Webster, R., Cardamone, M., et al. (2024) · Annals of Neurology
Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders
Cited by 23
- Verified
De novo missense variants in the E3 ubiquitin ligase adaptor KLHL20 cause a developmental disorder with intellectual disability, epilepsy, and autism spectrum disorder
Sleyp, Y., Valenzuela, I., Accogli, A., Ballon, K., Ben-Zeev, B., Berkovic, S. F., Broly, M., Callaerts, P., Caylor, R. C., Charles, P., et al. (2022) · Genetics in Medicine
Genetics and Neurodevelopmental DisordersGenomics and Rare Diseases
Cited by 10
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free